200,000+ products from a single source!
sales@angenechem.com
145455-35-2 | Butanamide, 3-[[(2R)-2-hydroxypropyl]amino]-3-methyl-N-[(3R)-2,3,4,5-tetrahydro-2-oxo-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-1-benzazepin-3-yl]-
CAS No: 145455-35-2 Catalog No: AG001D1X MDL No:
Product Description
Catalog Number:
AG001D1X
Chemical Name:
Butanamide, 3-[[(2R)-2-hydroxypropyl]amino]-3-methyl-N-[(3R)-2,3,4,5-tetrahydro-2-oxo-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-1-benzazepin-3-yl]-
CAS Number:
145455-35-2
Molecular Formula:
C32H37N7O3
Molecular Weight:
567.6813
IUPAC Name:
3-[[(2R)-2-hydroxypropyl]amino]-3-methyl-N-[(3R)-2-oxo-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-4,5-dihydro-3H-1-benzazepin-3-yl]butanamide
InChI:
InChI=1S/C32H37N7O3/c1-21(40)19-33-32(2,3)18-29(41)34-27-17-16-24-8-4-7-11-28(24)39(31(27)42)20-22-12-14-23(15-13-22)25-9-5-6-10-26(25)30-35-37-38-36-30/h4-15,21,27,33,40H,16-20H2,1-3H3,(H,34,41)(H,35,36,37,38)/t21-,27-/m1/s1
InChI Key:
AYBCFPXLXOLPIZ-JIPXPUAJSA-N
SMILES:
C[C@H](CNC(CC(=O)N[C@@H]1CCc2c(N(C1=O)Cc1ccc(cc1)c1ccccc1c1[nH]nnn1)cccc2)(C)C)O
Properties
Complexity:
895
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
2
Defined Bond Stereocenter Count:
0
Exact Mass:
567.296g/mol
Formal Charge:
0
Heavy Atom Count:
42
Hydrogen Bond Acceptor Count:
7
Hydrogen Bond Donor Count:
4
Isotope Atom Count:
0
Molecular Weight:
567.694g/mol
Monoisotopic Mass:
567.296g/mol
Rotatable Bond Count:
10
Topological Polar Surface Area:
136A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.8
Literature
| Title | Journal |
|---|---|
| Intracerebroventricular and intravenous administration of growth hormone secretagogue L-692,585, somatostatin, neuropeptide Y and galanin in pig: dose-dependent effects on growth hormone secretion. | Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20100501 |
| Stimulation of growth hormone secretion from seabream pituitary cells in primary culture by growth hormone secretagogues is independent of growth hormone transcription. | Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20041001 |
| Stimulatory effect of ghrelin on isolated porcine somatotropes. | Neuroendocrinology 20030601 |
| Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3',5'-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors. | Endocrinology 20021201 |
| Mechanism of action of the growth hormone secretagogue, L-692,585, on isolated porcine somatotropes. | The Journal of endocrinology 20021201 |
Related Products
© 2019 Angene International Limited. All rights Reserved.